Subspecialties: Page 1359

E-Z-EM sales and profit grow in Q3

By AuntMinnie.com staff writers

Contrast and virtual colonoscopy developer E-Z-EM reported strong growth in sales and net income for the third quarter (end-February 26), in part due to a voluntary recall of liquid barium products of one of its competitors.

April 7, 2005

Abbott gets FDA OK for ZoMaxx trial

By AuntMinnie.com staff writers

Interventional device developer Abbott Laboratories of Abbott Park, IL, said it has received conditional approval from the Food and Drug Administration for an investigational device exemption (IDE) application for the ZoMaxx drug-eluting stent.

April 6, 2005

E-Z-EM scores patent for NutraPrep

By AuntMinnie.com staff writers

Contrast and virtual colonoscopy developer E-Z-EM has received a patent from the U.S. Patent and Trademark Office for its NutraPrep preprocedure meal plan for virtual and optical colonoscopy.

April 6, 2005

Molecular imaging advances give hyperparathyroid patients more choices

By N. Shivapriya

Hyperparathyroidism is on the rise. An estimated two in 1,000 American women over age 40 suffer from the disease. Two recent studies have shed light on parathyroid imaging and minimally invasive radioguided surgery (MIRS) for the condition.

April 6, 2005

Radiation Therapy Services buys five centers

By AuntMinnie.com staff writers

Radiation therapy center operator Radiation Therapy Services has signed a definitive agreement to purchase five Nevada radiation treatment centers from Associated Radiation Oncologists.

April 5, 2005

Boston Scientific adds CE Mark

By AuntMinnie.com staff writers

Interventional device manufacturer Boston Scientific has received the European CE Mark for three large vessel sizes of its Taxus Express2 paclitaxel-eluting coronary stent system.

April 5, 2005